Additionally, as mentioned above, our in vivo experiment and clinical analyses showed that FOXP3 expression is inversely correlated with VEGF expression in breast cancer; and analysis of the data sets from the Kaplan–Meier plotter website also showed that the rate of VEGF upregulation in breast cancer samples with high FOXP3 expression was significantly reduced. This evidence concerns the gene FOXP3 and breast cancer.